Koyfin Home > Directory > Health Care > Abiomed Inc > Gross Margin

Abiomed Inc Gross Margin Chart (ABMD)

Abiomed Inc annual/quarterly Gross Margin from 2010 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Abiomed Inc Gross Margin for the quarter ending September 09, 2020 was $82m a -0.51% decrease of 0m year over year
  • Abiomed Inc Gross Margin for the last 12 months ending September 09, 2020 was $81m a -2.16% decrease of -2m year over year
  • Abiomed Inc Annual Gross Margin for 2020 was $82m a -1.41% decrease of -1m from 2019
  • Abiomed Inc Annual Gross Margin for 2019 was $83m a -0.28% decrease of 0m from 2018
  • Abiomed Inc Annual Gross Margin for 2018 was $83m a -0.89% decrease of -1m from 2017
Other Margins & Efficiency Metrics:
  • Abiomed Inc EBITDA Margin for the quarter ending December 12, 2018 was $33m a 11.61% increase of 4m year over year
  • Abiomed Inc Return on Capital % for the quarter ending December 12, 2018 was 18.96 a 5.11% increase of 0.97 year over year
  • Abiomed Inc Return on Equity % for the quarter ending December 12, 2018 was 21.82 a -2.17% decrease of -0.47 year over year
View Chart On Koyfin

Quarterly ABMD Gross Margin Data

09/2020$82m
06/2020$78m
03/2020$81m
12/2019$82m
09/2019$83m
06/2019$82m
03/2019$83m
12/2018$83m
09/2018$84m
06/2018$83m

Annual ABMD Gross Margin Data

2020$82m
2019$83m
2018$83m
2017$84m
2016$85m
2015$83m
2014$80m
2013$80m
2012$81m
2011$78m